- Home
- TACH vs CADL Comparison
TACH vs CADL Comparison
Compare TACH & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACH
- CADL
- Stock Information
- Founded
- TACH 2024
- CADL 1999
- Country
- TACH United States
- CADL United States
- Employees
- TACH N/A
- CADL N/A
- Industry
- TACH
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TACH
- CADL Health Care
- Exchange
- TACH Nasdaq
- CADL Nasdaq
- Market Cap
- TACH 351.2M
- CADL 339.8M
- IPO Year
- TACH 2025
- CADL 2021
- Fundamental
- Price
- TACH $10.19
- CADL $5.48
- Analyst Decision
- TACH
- CADL Strong Buy
- Analyst Count
- TACH 0
- CADL 7
- Target Price
- TACH N/A
- CADL $19.57
- AVG Volume (30 Days)
- TACH 133.6K
- CADL 852.2K
- Earning Date
- TACH 01-01-0001
- CADL 11-13-2025
- Dividend Yield
- TACH N/A
- CADL N/A
- EPS Growth
- TACH N/A
- CADL N/A
- EPS
- TACH 0.19
- CADL N/A
- Revenue
- TACH N/A
- CADL N/A
- Revenue This Year
- TACH N/A
- CADL N/A
- Revenue Next Year
- TACH N/A
- CADL N/A
- P/E Ratio
- TACH $53.35
- CADL N/A
- Revenue Growth
- TACH N/A
- CADL N/A
- 52 Week Low
- TACH $10.00
- CADL $3.79
- 52 Week High
- TACH $10.38
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TACH N/A
- CADL 48.58
- Support Level
- TACH N/A
- CADL $5.11
- Resistance Level
- TACH N/A
- CADL $5.80
- Average True Range (ATR)
- TACH 0.00
- CADL 0.37
- MACD
- TACH 0.00
- CADL -0.04
- Stochastic Oscillator
- TACH 0.00
- CADL 24.66
About TACH Titan Acquisition Corp. Class A Ordinary Shares
Titan Acquisition Corp is a blank check company.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.